Altered transport properties of pentamidine-resistant Leishmania donovani and L. amazonensis promastigotes.
Pentamidine-resistant clones of Leishmania donovani and L. amazonensis promastigotes were developed by increase of the drug pressure in the culture medium and characterized. The resistant clones could grow in 40 and 20 microM pentamidine as determined for L. donovani and L. amazonensis, respectively, with 50% inhibitory concentrations (IC50 values) being 140 and 60 microM, which were 18 and 75 times higher than those recorded for the parental clones, respectively. Biochemical analysis of the clones showed that the acquired pentamidine resistance was specific (no cross-resistance to unrelated drugs and no reversibility with verapamil) and stable in vitro and in vivo. Pentamidine resistance is related to decreased drug uptake and highly increased efflux in both clones of Leishmania spp., accompanied by an alteration in polyamine carriers. Furthermore, a modification of the uptake of pyrimidine nucleosides and several amino acids by these resistant clones indicates alterations in the surface membrane.
Basselin
M
M
Institut de Chimie des Substances Naturelles, C.N.R.S., Gif-sur Yvette, France.
Lawrence
F
F
Robert-Gero
M
M
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D000981:Antiprotozoal Agents / Q000378:metabolism / Q000494:pharmacology*; D001692:Biological Transport; D004351:Drug Resistance; D007893:Leishmania donovani / Q000187:drug effects* / Q000254:growth & development; D007894:Leishmania mexicana / Q000187:drug effects* / Q000254:growth & development; D009705:Nucleosides / Q000378:metabolism; D010419:Pentamidine / Q000378:metabolism / Q000494:pharmacology*; D011073:Polyamines / Q000378:metabolism
D000596:Amino Acids; D000981:Antiprotozoal Agents; D009705:Nucleosides; D011073:Polyamines; D010419:Pentamidine